Doron Cohen - Cellcom Israel Chairman of the Board
Insider
Doron Cohen is Chairman of the Board of Cellcom Israel since 2020.
| Age | 66 |
| Tenure | 4 years |
| Phone | 972 52 999 0052 |
| Web | http://www.cellcom.co.il |
Cellcom Israel Management Efficiency
The company has Return on Asset of (0.17) % which means that on every $100 spent on assets, it lost $0.17. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (10.15) %, meaning that it generated no profit with money invested by stockholders. Cellcom Israel's management efficiency ratios could be used to measure how well Cellcom Israel manages its routine affairs as well as how well it operates its assets and liabilities.Cellcom Israel has 956.5 M in debt with debt to equity (D/E) ratio of 1.92, which is OK given its current industry classification. Cellcom Israel has a current ratio of 1.07, demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Cellcom to invest in growth at high rates of return.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Sergio MSc | Lion One Metals | N/A | |
| PE MBA | Lion One Metals | 64 | |
| Scott Huckins | SunOpta | 57 | |
| Barbara Wood | Sellas Life Sciences | 61 | |
| Mark Lappe | Inhibrx | 57 | |
| Quinn Deveraux | Inhibrx | N/A | |
| Jrg Breitkopf | Sellas Life Sciences | N/A | |
| Tony CA | Lion One Metals | N/A | |
| Perry Celentano | Valneva SE ADR | N/A | |
| ScD MD | Sellas Life Sciences | 48 | |
| John CPA | Sellas Life Sciences | 39 | |
| Michael Buick | SunOpta | 48 | |
| Darren Holden | Lion One Metals | N/A | |
| Barend Reijn | SunOpta | 42 | |
| Gerald Strohmaier | Valneva SE ADR | N/A | |
| Stephanie Martel | Lion One Metals | N/A | |
| BS CPA | Inhibrx | 42 | |
| Laetitia BachelotFontaine | Valneva SE ADR | N/A | |
| David Largey | SunOpta | 62 | |
| Jeffrey Edelen | Lion One Metals | N/A | |
Management Performance
| Return On Equity | -10.15 | |||
| Return On Asset | -0.17 |
Cellcom Israel Leadership Team
Elected by the shareholders, the Cellcom Israel's board of directors comprises two types of representatives: Cellcom Israel inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cellcom. The board's role is to monitor Cellcom Israel's management team and ensure that shareholders' interests are well served. Cellcom Israel's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cellcom Israel's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Diana Dan, Director | ||
| Teimuraz Romashvili, Vice President of Pre-Paid Activity | ||
| Liat MenahemiStadler, Vice President of Legal Affairs and Corporate Secretary | ||
| Ronnen Shles, Controller | ||
| Shlomi Fruhling, Chief Financial Officer | ||
| Varda Liberman, Director | ||
| Victor Malka, Chief Information Officer | ||
| Shmuel Hauser, Director | ||
| Atara LitvakShacham, Vice President - Excellence and Innovation | ||
| Doron Cohen, Chairman of the Board | ||
| Nadav Amsalem, Vice President-Business Customers | ||
| Aaron Kaufman, Director | ||
| Eran Shenar, Director | ||
| Orly Pascal, Vice President of Human Resources | ||
| Yaniv Koriat, Chief Technology Officer | ||
| Yoram Turbowicz, Director | ||
| Shai Amsalem, Chief Financial Officer | ||
| Gustavo Traiber, Independent Director | ||
| Ephraim Kunda, Independent Director | ||
| Mauricio Wior, Vice Chairman of the Board | ||
| Avi Gabbay, Chief Executive Officer | ||
| Amos Maor, Vice President - Sales and Service |
Cellcom Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cellcom Israel a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -10.15 | |||
| Return On Asset | -0.17 | |||
| Profit Margin | (4.98) % | |||
| Current Valuation | 613.79 M | |||
| Shares Outstanding | 162.78 M | |||
| Shares Owned By Insiders | 47.60 % | |||
| Shares Owned By Institutions | 17.74 % | |||
| Number Of Shares Shorted | 40.51 K | |||
| Price To Earning | 223.44 X | |||
| Price To Book | 0.94 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Cellcom Stock
If you are still planning to invest in Cellcom Israel check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cellcom Israel's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |